相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy in angiotensin receptor blockade: a comparative review of data with olmesartan
Josep Redon et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2009)
α/βHydrolase Fold: An Update
David L. Ollis et al.
PROTEIN AND PEPTIDE LETTERS (2009)
Olmesartan medoxomil - A review of its use in the management of hypertension
Lesley J. Scott et al.
DRUGS (2008)
Molecular basis of prodrug activation by human valacyclovirase, an α-amino acid ester hydrolase
Longsheng Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Rapid method for the quantification of amoxicillin and its major metabolites in pig tissues by liquid chromatography-tandem mass spectrometry with emphasis on stability issues
Tim Reyns et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs
Masakiyo Hosokawa
MOLECULES (2008)
Amlodipine/ARB fixed-dose combinations for the treatment of hypertension: Focus on amlodipine/olmesartan combination
Steven G. Chrysant
DRUGS OF TODAY (2008)
The Pfam protein families database
Robert D. Finn et al.
NUCLEIC ACIDS RESEARCH (2008)
Faropelnem: review of a new oral penem
Kristen N. Schurek et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Large-scale mapping of human protein-protein interactions by mass spectrometry
Rob M. Ewing et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
Structure, function and regulation of carboxylesterases
Tetsuo Satoh et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
MODBASE: a database of annotated comparative protein structure models and associated resources
Ursula Pieper et al.
NUCLEIC ACIDS RESEARCH (2006)
Human carboxylesterase isozymes: Catalytic properties and rational drug design
Teruko Imai
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Enzymes involved in the bioconversion of ester-based prodrugs
Bianca M. Liederer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Metabolism of melatonin by human cytochromes P450
XC Ma et al.
DRUG METABOLISM AND DISPOSITION (2005)
The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity
RW James et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Prodrug research: futile or fertile?
B Testa
BIOCHEMICAL PHARMACOLOGY (2004)
Pharmacogenetics of paraoxonases: a brief review
DI Draganov et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Lessons learned from marketed and investigational prodrugs
P Ettmayer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist
K Beaumont et al.
CURRENT DRUG METABOLISM (2003)
Identification of a human valacyclovirase - Biphenyl hydrolase-like protein as valacyclovir hydrolase
I Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: Two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography
K Kubota et al.
PROTEOMICS (2003)
Candesartan cilexetil - An update of its use in essential hypertension
SE Easthope et al.
DRUGS (2002)
Cardiovascular responsivity to stress in adolescents with and without persistently elevated blood pressure
PG Saab et al.
JOURNAL OF HYPERTENSION (2001)